Johnson & Johnson giving $200M to boost health of women, children in poor countries
J&J giving $200 million for health of women, kids New FDA report shows multiple lapses in procedures at Johnson & Johnson plant in Pennsylvania
New FDA report shows multiple lapses at J&J plant J&J partner says EU rejecting drug for MRSA, other skin infections over problems with testing
J&J partner says EU rejecting skin infection drug Drug, device maker Johnson & Johnson posts 1 percent rise in 3Q profit despite lower salesJ&J posts 1 percent profit rise despite sales drop TRENTON, N.J. — Johnson & Johnson on Tuesday reported a meager 1 percent increase in third-quarter profit, as intensifying generic competition slashed sales of blockbuster prescription drugs. In addition, the global recession hurt consumer product sales and slowed growth for medical devices, the only J&J segment not declining. Johnson & Johnson makes 4 deals, awaits new product approvals amid slumping salesJ&J wheels and deals, awaits new product approvals NEW BRUNSWICK, N.J. — Johnson & Johnson, the world’s biggest healthcare company and a Dow Jones industrial average component, reports earnings for the third quarter Tuesday morning. Here’s a summary of key developments and analyst opinion related to the period. |
|
